Literature DB >> 29634751

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

Alberto C Guardo, Carmen Elena Gómez, Vicens Díaz-Brito, Judit Pich, Joan Albert Arnaiz, Beatriz Perdiguero, Juan García-Arriaza, Nuria González, Carlos O S Sorzano, Laura Jiménez, José Luis Jiménez, María Ángeles Muñoz-Fernández, José M Gatell, José Alcamí, Mariano Esteban, Juan Carlos López Bernaldo de Quirós, Felipe García, Montserrat Plana.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0186602.].

Entities:  

Year:  2018        PMID： 29634751      PMCID： PMC5892918          DOI： 10.1371/journal.pone.0195915

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


  1 in total

1.  Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

Authors:  Alberto C Guardo; Carmen Elena Gómez; Vicens Díaz-Brito; Judit Pich; Joan Albert Arnaiz; Beatriz Perdiguero; Juan García-Arriaza; Nuria González; Carlos O S Sorzano; Laura Jiménez; José Luis Jiménez; María Ángeles Muñoz-Fernández; José M Gatell; José Alcamí; Mariano Esteban; Juan Carlos López Bernaldo de Quirós; Felipe García; Montserrat Plana
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240
  1 in total
  1 in total

1.  A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.

Authors:  Beatriz Perdiguero; Cristina Sánchez-Corzo; Carlos Oscar S Sorzano; Lidia Saiz; Pilar Mediavilla; Mariano Esteban; Carmen Elena Gómez
Journal:  Viruses       Date:  2019-02-16       Impact factor: 5.048
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.